Public Company News

Silicon Motion Unveils New USB Display Interface SoC Enabling Cost-Effective Universal Docking Stations with Support for Multiple Ultra-High Definition Displays.

The SM770 supports up to three 4K 60Hz UHD displays and up to 144Hz display, allowing flexible connections with PC notebooks, ideally for commercial use, shared office users, and gamers. TAIPEI and MILPITAS, Calif., June 3, 2024 /PRNewswire/ -- Silicon Motion Technology Corporation (NasdaqG...

2024-06-03 21:00 3542

Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification

News Summary: * Waters becomes the first vendor to obtain ACT™ Ecolabel Certification for 42 of its liquid chromatography columns, providing independent validation of the environmental impact of Waters column manufacturing, use, packaging, and disposal. * Laboratory products that earn the AC...

2024-06-03 20:00 2503

Trinasolar Releases Sustainability Report for 2023, Detailing its Commitment, Action and Achievements Towards a More Sustainable World

CHANGZHOU, China, June 3, 2024 /PRNewswire/ -- Trina Solar Co., Ltd. (688599. SH), one of the world's leaders in smart PV and energy storage solutions, recently released its2023 Sustainability Report ...

2024-06-03 17:43 2913

BRI Receives Analysts Buy Recommendation as MSMEs Financing Strategy Drives Growth

JAKARTA, Indonesia, June 3, 2024 /PRNewswire/ -- PT. Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI)remains Indonesia's leading MSME (Micro, Small and Medium Enterprise) financier, with its credit portfolio growing toIDR 1,308.65 trillion by March 2024, up 10.89% year-on-year. Over 83% of this, o...

2024-06-03 17:16 4473

Ericsson announces conclusion of Monitorship

* Ericsson's Monitorship and Plea Agreement concluded on June 2 * Follows upon certification of Ericsson's anti-corruption compliance program by independent Monitor inMarch 2024 * Continuing to cooperate fully with DOJ and SEC investigations on historical conduct STOCKHOLM, June 3, 2024 /PRN...

2024-06-03 14:40 2049

Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan

Working with Datasection, KDDI, and Sharp, Supermicro Will Deploy Rack Scale Plug-and-Play Liquid-Cooled AI Solutions with Advanced NVIDIA GPUs at a New AI Data Center -- AI Data Centers with Green Computing Can be Free with a Bonus  SAN JOSE, Calif. and TAIPEI, June 3, 2024 /PRNewswire/ -- Compu...

2024-06-03 10:58 3053

Alphamab Oncology Presented Chinese Clinical Data of Anti-HER2 Bispecific ADC JSKN003 for the First Time at the 2024 ASCO Annual Meeting

* Results from the phase I part of JSKN003-102 was reported at this ASCO Annual Meeting. * JSKN003 exhibited a favorable tolerability and manageable safety profile in heavily pretreated patients with advanced/metastatic solid tumors and demonstrated encouraging antitumor activity during dose ...

2024-06-03 10:17 2412

Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer at 2024 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and ot...

2024-06-03 09:44 3253

Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer and Gastric Cancer

SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2024-06-03 09:35 4005

Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging

MELBOURNE, Australia, June 3, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License Application (BLA) tothe United States (U.S.) Food and Drug Administration (FDA) for its investigational radi...

2024-06-03 09:08 2137

Kerry Logistics Network Commended for Comprehensive Climate Disclosure at the HKQAA Hong Kong Green and Sustainability Contribution Awards 2024

HONG KONG, June 3, 2024 /PRNewswire/ -- Kerry Logistics Network Limited ('Kerry Logistics Network', 'KLN'; Stock Code 0636.HK) is delighted to be recognised once again by the Hong Kong Quality Assurance Agency ('HKQAA'), winning the Pioneering Award for Climate Disclosure Contribution for its not...

2024-06-03 08:07 2534

DB HiTek Advances Global Shutter and SPAD

* Expanding specialized image sensor business applied to machine vision, autonomous vehicles, robotics, and medical devices * Collaborating on product development with leading companies in the US, Japan , andChina by providing global leading-edge processes SEOUL, South Korea, June 3, 2024 /PRN...

2024-06-03 08:00 3328

Kerry Logistics Network Named Global Logistics Company of Excellence by Hong Kong Economic Journal Corporate Brand Awards of Excellence 2024

HONG KONG, June 3, 2024 /PRNewswire/ -- Kerry Logistics Network Limited ('Kerry Logistics Network', 'KLN'; Stock Code 0636.HK) has been named the Global Logistics Company of Excellence by the Hong Kong Economic Journal Corporate Brand Awards of Excellence (the 'Awards') 2024, for its excellent co...

2024-06-03 07:11 3249

Innovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2024-06-02 13:19 5005

CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC

* EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalimab in combination with chemotherapy as a first-line treatment for non-small cell lung cancer (NSC...

2024-06-02 08:24 4315

Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...

2024-06-02 08:00 6090

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...

2024-06-02 08:00 4540

Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmolog...

2024-06-02 08:00 4818

KED INVESTOR ALERT: Kaskela Law LLC Announces Investigation of Keypath Education International, Inc. (ASX: KED) and Encourages Investors to Contact the Firm

PHILADELPHIA, June 1, 2024 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Keypath Education International, Inc. (ASX: KED) ("Keypath") on behalf of the company's investors. On May 24, 2024, Keypath disclosed that it had entered into an Agreement and Plan of Merger whereby the...

2024-06-01 09:14 2924

Sungrow Hosts an Event Highlighting its New C&I String Inverter SG50CX-P2-JP in Japan

TOKYO, May 31, 2024 /PRNewswire/ -- Sungrow, a global leading PV inverter and energy storage system provider, successfully hosted an event showcasing its innovative C&I String Inverter SG50CX-P2-JP, tailor-made for the Japanese market. The launch event garnered significant attention, drawing over...

2024-05-31 19:39 3190
1 ... 301302303304305306307 ... 891